Funding news for global health researchers: January 6, 2025

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Special Announcements

Last Chance! Submit your Poster Abstract to the NIDA International Forum

Present your international drug use and addiction research during the 2025 NIDA International Forum, which will be held June 13–14, 2025, in New Orleans, Louisiana, USA.

• Submission Deadline: January 12, 2025
• More Information

Just Announced Fogarty Funding Opportunities

mHealth Opportunity from Fogarty

The overall goal of the program is to develop an evidence base for the use of mHealth technology to improve clinical and public health outcomes, and also to strengthen mHealth research capacity in LMICs. This NOFO provides support for up to two years for technology development and feasibility studies, followed by a possible transition to expanded research support for validation, larger-scale feasibility, and effectiveness studies.

• Application due date: March 21, 2025; March 20, 2026
• Read funding opportunity (PAR-25-242)
• Learn more about the mHealth program
  

Upcoming Deadlines for Fogarty Funding Opportunities

• Japanese Research Fellowships (JSPS)
  Application deadline: February 14, 2025
  
• International Research Scientist Development Award (IRSDA)
  Application deadline: March 10, 2025
  
• Mobile Health
  Application deadline: March 21, 2025
  

Upcoming deadlines for all Fogarty funding opportunities

Funding opportunities on which Fogarty is a partner:

• NIMHD Minority Health and Health Disparities Research Training (MHRT) Program (T37 Clinical Trial Not Allowed) (RFA-MD-25-001)
  Application due date: January 10, 2025
• Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) (PAR-25-233)
  Application due date: Multiple dates, see announcement.
• Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) (PAR-25-143)
  Application due date: Multiple dates, see announcement.

Administrative supplements for current Fogarty grant recipients:

• Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional) (NOT-OD-25-015) 
  Expiration date: January 24, 2025
  
• Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) (PA-20-272) 
  Expiration date: January 24, 2025
  
• Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards (NOT-OD-23-032) 
  Expiration date: October 1, 2025
  

All administrative supplements

Funding Opportunities

NIH funding opportunities focusing on global health and foreign collaboration:

• Integrating Mental Health Care into Health Care Systems and Non-Health Settings in Low- and Middle-Income Countries (R01 Clinical Trial Optional) (PAR-25-201)
  Application due date: Multiple dates, see announcement.
• Career Development Opportunities for Research on Cancer in Global Settings at the Center for Global Health at the National Cancer Institute  (NOT-CA-24-098)
  Application due date: Multiple dates, see announcement.
• Small Research Grant Program for the Next Generation of Researchers in Low- and Middle-Income Countries (LMICs) for Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Research (R03 Clinical Trial Not Allowed) (RFA-AG-25-031)
  Application due date: Multiple dates, see announcement.
• Consortium for Neuroscience AD/ADRD in Low- and Middle-Income Countries (U01 Clinical Trial Not Allowed) (RFA-AG-25-032)
  Application due date: Multiple dates, see announcement.

More NIH funding opportunities focused on areas relevant to global health

NIH funding opportunities for which foreign organizations and/or foreign components of U.S. organizations may apply:

• Advancing Vision Health Equity through Multi-level Interventions and Community-Engaged Research (R01 - Clinical Trial Optional) (RFA-EY-25-002)
  Application due date: March 3, 2025
• Ex Vivo Models for Studies at the Intersection of HIV and Addictive Substance Use (R01 Clinical Trial Not Allowed) (RFA-DA-25-074)
  Application due date: August 13, 2025
• NIAID, NIDDK, NIDA, and NIAAA Research Opportunities for New and "At-Risk" Investigators (R01 Clinical Trial Optional) (PA-25-249)
  Application due date: Multiple dates, see announcement.
• Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed) (PAR-25-056)
  Application due date: Multiple dates, see announcement.
• Planning for Product Development Strategy (R34 Clinical Trial Not Allowed) (PAR-25-099)
  Application due date: Multiple dates, see announcement.
• Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) (PAR-25-101)
  Application due date: Multiple dates, see announcement.
• Innovative Mental Health Services Research Not Involving Clinical Trials funding opportunities:
  • R01 Clinical Trials Not Allowed (PAR-25-283)
    Application due date: Multiple dates, see announcement.
  • R34 Clinical Trial Not Allowed (PAR-25-284)
    Application due date: Multiple dates, see announcement.
• Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) (PAR-25-328)
  Application due date: Multiple dates, see announcement.
• Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional) (PAR-25-329)
  Application due date: Multiple dates, see announcement.
• Research on Current Topics in Alzheimer's Disease and Its Related Dementias funding opportunities:
  • R21 Clinical Trial Optional (PAR-25-331)
    Application due date: Multiple dates, see announcement.
  • R01 Clinical Trial Optional (PAR-25-332)
    Application due date: Multiple dates, see announcement.
• Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment funding opportunities:
  • R01 - Clinical Trial Optional (PAR-25-337)
    Application due date: Multiple dates, see announcement.
  • R01 - Clinical Trial Not Allowed (PAR-25-338)
    Application due date: Multiple dates, see announcement.
• NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed) (PAR-25-357)
  Application due date: Multiple dates, see announcement.
• Early Immune System Development and Ontogeny (R01 Clinical Trial Optional) (PAR-25-362)
  Application due date: Multiple dates, see announcement.
• Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimer’s Disease and Related Dementias (R01 Clinical Trial Not Allowed) (PAR-25-374)
  Application due date: Multiple dates, see announcement.
• Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research funding opportunities:
  • R01 Clinical Trial Optional (RFA-CA-25-005)
    Application due date: Multiple dates, see announcement.
  • U01 Clinical Trial Optional (RFA-CA-25-006)
    Application due date: Multiple dates, see announcement.
  • P50 Clinical Trial Optional (RFA-CA-25-007)
    Application due date: Multiple dates, see announcement.

NIH funding opportunities for which foreign components may apply:

• NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement funding opportunities:
  • U01 Clinical Trial Required (PA-25-147)
    Application due date: Multiple dates, see announcement.
  • U01 Clinical Trial Not Allowed (PAR-25-089)
    Application due date: Multiple dates, see announcement.
  • Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed) (PAR-25-347)
    Application due date: Multiple dates, see announcement.

Other Funding News

General Notices:

• Request for Information on the National Institute on Aging Health Disparities Research Framework (NOT-AG-24-086)
  Response date: January 17, 2025
• Notice Announcing the National Institute of Mental Health (NIMH) Expectations for Collection of Common Data Elements (NOT-MH-25-055)
  Response date: April 1, 2025

Notices of changes to NIH funding opportunities:

• Notice of Change: NIDA Participation in RFA-EY-25-001: BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) (NOT-DA-24-064)
• Notice of change in "Funding Opportunity Goals" for RFA-EY-25-001 "BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)" (NOT-EY-25-004)

NIH Notices of Special Interest (NOSIs):

• Human Cell Biology of Alzheimer's Disease Genetic Variants (NOT-AG-24-039)
  Expiration date: November 17, 2027
  
• Mechanisms Driving Obesity and Prostate Cancer Risk (NOT-CA-25-002)
  Expiration date: January 8, 2028
  
• Bold New Bioengineering Research for Heart, Lung, Blood and Sleep Disorders (NOT-HL-24-037)
  Expiration date: January 8, 2028
  

Non-NIH funding opportunities:

• HealthTech Hub Africa is seeking ventures from across Africa with innovative solutions and business models allowing for collaboration with local and national governments and aiming to solve health challenges and/or support public health systems in their digital transformation.
  Application deadline: January 17, 2024
• The American Heart Association is piloting the 2025 International Visiting Professorship Award to bring internationally based scientists to the U.S. for one week to foster scientific exchange. The goal of the program is to expand research experiences and collaborative opportunities for both the awarded Visiting Professor and his/her U.S.-based host in areas of research that align with the mission of the AHA.
  Application deadline: February 4, 2025

More non-NIH funding opportunities

Training Opportunities

Cornell Accepting Applications for Global Women’s Health Training

Applications are now open for the Global Infectious Diseases across a Woman's Lifespan Course, and the Women’s Infectious Diseases in Global Health Scholars (WINGS) Program. 

• Applications due: January 31, 2025
• Apply here
  

Manuscript, Abstract & Poster Submission Opportunities

• The National Cancer Institute is now accepting proposals for the annual ASGCR Symposium on Global Cancer Research. The theme of this year’s symposium is New Models for Participatory Research in Global Oncology: Elevating the Voices of Patients and Providers.
  • Symposium dates: May 5-8, 2025
  • Submissions due: January 17, 2025
• The Abstract Submission portal for INTEREST 2025, being held May 13-16, 2025, in Windhoek, Namibia, is now open. Successful candidates will be invited for an oral, mini-oral, or poster presentation.
  • Submissions due: January 17, 2025
• Beyond Global Health (BGH) is interested in how people from the Global North and Global South share their understanding of the concept of “Global Health.” Rather than exploring this through scientific journals and manuscripts, BGH is looking to expand on this idea through poetry, art, prose, and photography. Submissions are currently being accepted through the BGH website from researchers, participants, global health professionals, recipients of global health interventions, and anyone passionate about global health.
  • Submissions due: February 17, 2025

Events

Events for global health researchers:

• Emerging and Re-Emerging Infectious Diseases: A Perpetual Challenge

  • Date: January 7
  • Location: Virtual
  • Part of the 2025 Demystifying Medicine Series
  • Sponsored by FAES and NIH

Fogarty calendar of events